Huntington National Bank’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
Huntington National Bank's AIM Position: Q2 2025 in Review
Huntington National Bank sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1 share — an estimated $7 sold.
Huntington National Bank first reported a position in AIM in Q2 2018 and held it in 28 quarters. The position peaked at $38 in Q2 2023. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- Huntington National Bank reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- Huntington National Bank sold 1 AIM ImmunoTech share in Q2 2025, an estimated $7.
- Huntington National Bank first reported a position in AIM ImmunoTech in Q2 2018 and held it in 28 quarters.
- Huntington National Bank's AIM ImmunoTech position peaked at $38 in Q2 2023.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.